|
MCM4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.01379999950524E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.19979981084396E-10 |
| Normal-vs-Stage2 |
7.29719999981171E-07 |
| Normal-vs-Stage3 |
2.26999999999311E-05 |
| Normal-vs-Stage4 |
2.560400E-01 |
| Stage1-vs-Stage2 |
6.030400E-01 |
| Stage1-vs-Stage3 |
8.810200E-01 |
| Stage1-vs-Stage4 |
7.659900E-02 |
| Stage2-vs-Stage3 |
6.096000E-01 |
| Stage2-vs-Stage4 |
5.938200E-02 |
| Stage3-vs-Stage4 |
1.244380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.01070000035897E-07 |
| Normal-vs-AfricanAmerican |
1.757030E-04 |
| Normal-vs-Asian |
9.334200E-01 |
| Caucasian-vs-AfricanAmerican |
6.559200E-01 |
| Caucasian-vs-Asian |
5.190800E-01 |
| AfricanAmerican-vs-Asian |
4.821000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.19669999652106E-08 |
| Normal-vs-Female |
3.82589999999849E-05 |
| Male-vs-Female |
3.421200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.391560E-01 |
| Normal-vs-Age(41-60Yrs) |
2.21239999997902E-06 |
| Normal-vs-Age(61-80Yrs) |
8.55210000039186E-07 |
| Normal-vs-Age(81-100Yrs) |
6.90220000043595E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.717800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.091800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.758500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.145000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.676340E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.262400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.546200E-02 |
| Normal-vs-Grade 2 |
1.47860002019939E-09 |
| Normal-vs-Grade 3 |
1.32680000319851E-08 |
| Normal-vs-Grade 4 |
4.827400E-01 |
| Grade 1-vs-Grade 2 |
4.581000E-01 |
| Grade 1-vs-Grade 3 |
4.093400E-01 |
| Grade 1-vs-Grade 4 |
4.114000E-01 |
| Grade 2-vs-Grade 3 |
5.580400E-01 |
| Grade 2-vs-Grade 4 |
8.423700E-02 |
| Grade 3-vs-Grade 4 |
5.934400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.44999567908144E-11 |
| Normal-vs-ccB subtype |
7.660800E-03 |
| ccA subtype-vs-ccB subtype |
1.215350E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.93020000041722E-07 |
| Normal-vs-N1 |
6.230800E-01 |
| N0-vs-N1 |
6.571600E-02 |
|
|
